Patents by Inventor Ghislaine Cherel

Ghislaine Cherel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8741286
    Abstract: The present invention relates to chimeric derivatives of serine protease zymogen containing the activation peptide of factor X or a fragment thereof for improving the half-life of said derivatives. Preferably, said chimeric derivatives are protein C and factor X derivatives. The invention also relates to said derivatives for the prevention or treatment of blood coagulation disorders.
    Type: Grant
    Filed: June 4, 2013
    Date of Patent: June 3, 2014
    Assignee: Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Olivier Christophe, Cecile Denis, Ghislaine Cherel, Paul Gueguen
  • Publication number: 20130261060
    Abstract: The present invention relates to chimeric derivatives of serine protease zymogen containing the activation peptide of factor X or a fragment thereof for improving the half-life of said derivatives. Preferably, said chimeric derivatives are protein C and factor X derivatives. The invention also relates to said derivatives for the prevention or treatment of blood coagulation disorders.
    Type: Application
    Filed: June 4, 2013
    Publication date: October 3, 2013
    Applicant: Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Olivier Christophe, Cecile Denis, Ghislaine Cherel, Paul Gueguen
  • Patent number: 8518400
    Abstract: The present invention relates to chimeric derivatives of serine protease zymogen containing the activation peptide of factor X or a fragment thereof for improving the half-life of said derivatives. Preferably, said chimeric derivatives are protein C and factor X derivatives. The invention also relates to said derivatives for the prevention or treatment of blood coagulation disorders.
    Type: Grant
    Filed: January 2, 2013
    Date of Patent: August 27, 2013
    Assignee: Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Olivier Christophe, Cecile Denis, Ghislaine Cherel, Paul Gueguen
  • Patent number: 8436144
    Abstract: The present invention relates to chimeric derivatives of serine protease zymogen containing the activation peptide of factor X or a fragment thereof for improving the half-life of said derivatives. Preferably, said chimeric derivatives are protein C and factor X derivatives. The invention also relates to said derivatives for the prevention or treatment of blood coagulation disorders.
    Type: Grant
    Filed: December 21, 2009
    Date of Patent: May 7, 2013
    Assignee: Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Olivier Christophe, Cecile Denis, Ghislaine Cherel, Paul Gueguen
  • Publication number: 20110293597
    Abstract: The present invention relates to chimeric derivatives of serine protease zymogen containing the activation peptide of factor X or a fragment thereof for improving the half-life of said derivatives. Preferably, said chimeric derivatives are protein C and factor X derivatives. The invention also relates to said derivatives for the prevention or treatment of blood coagulation disorders.
    Type: Application
    Filed: December 21, 2009
    Publication date: December 1, 2011
    Inventors: Olivier Christophe, Cecile Denis, Ghislaine Cherel, Paul Gueguen